Identification of TL-Om1, an adult T-cell leukemia (ATL) cell line, as reference material for quantitative PCR for human T-lymphotropic virus 1

Journal of Clinical Microbiology

Volumn 53, Issue 2, 2015, Pages 587-596

  Kuramitsu, Madoka ^a   Okuma, Kazu ^a   Yamagishi, Makoto ^b   Yamochi, Tadanori ^b   Firouzi, Sanaz ^b   Momose, Haruka ^a   Mizukami, Takuo ^a   Takizawa, Kazuya ^a   Araki, Kumiko ^a   Sugamura, Kazuo ^c   Yamaguchi, Kazunari ^a   Watanabe, Toshiki ^b   Hamaguchi, Isao ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c MIYAGI CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RIBONUCLEASE P;

ADULT; ALB GENE; ARTICLE; CHROMOSOME 1; CLONAL SPECIES; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; GENETIC STABILITY; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; JURKAT CELL LINE; KARYOTYPING; NONHUMAN; POLYMERASE CHAIN REACTION; QUANTITATIVE POLYMERASE CHAIN REACTION; RPPH1 GENE; T-CELL LEUKEMIA CELL LINE; TL OM1 CELL LINE; VIRUS DNA CELL DNA INTERACTION; VIRUS GENE; VIRUS GENOME; VIRUS INFECTIVITY; EVALUATION STUDY; GENETICS; HUMAN T-LYMPHOTROPIC VIRUS 1; ISOLATION AND PURIFICATION; JAPAN; PROCEDURES; PROVIRUS; REAL TIME POLYMERASE CHAIN REACTION; STANDARD; STANDARDS; TUMOR CELL LINE; VIRUS LOAD;

HUMAN T-LYMPHOTROPIC VIRUS 1;

CELL LINE, TUMOR; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; JAPAN; PROVIRUSES; REAL-TIME POLYMERASE CHAIN REACTION; REFERENCE STANDARDS; VIRAL LOAD;

EID: 84921752688     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02254-14     Document Type: Article

References (28)

1. Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI, Shirakawa S, Miyoshi I. 1981. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 78:6476-6480. http://dx.doi.org/10.1073/pnas.78.10.6476.
2. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77:7415-7419. http://dx.doi.org/10.1073/pnas.77.12.7415.
3. Watanabe T. 1997. HTLV-1-associated diseases. Int J Hematol 66:257-278. http://dx.doi.org/10.1016/S0925-5710(97)00077-7.
4. Gessain A, Cassar O. 2012. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol 3:388. http://dx.doi.org/10.3389/fmicb.2012.00388.
5. Watanabe T. 2011. Current status of HTLV-1 infection. Int J Hematol 94:430-434. http://dx.doi.org/10.1007/s12185-011-0934-4.
6. Satake M, Yamaguchi K, Tadokoro K. 2012. Current prevalence of HTLV-1in Japan asdeterminedbyscreeningofblood donors. JMed Virol 84:327-335. http://dx.doi.org/10.1002/jmv.23181.
7. Iwanaga M, Watanabe T, Utsunomiya A, Okayama A, Uchimaru K, Koh KR, Ogata M, Kikuchi H, Sagara Y, Uozumi K, Mochizuki M, Tsukasaki K, Saburi Y, Yamamura M, Tanaka J, Moriuchi Y, Hino S, Kamihira S, Yamaguchi K, Joint Study on Predisposing Factors of ATLDi. 2010. Human T-cell leukemia virus type I(HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood 116:1211-1219. http://dx.doi.org/10.1182/blood-2009-12-257410.
8. Takenouchi N, Yamano Y, Usuku K, Osame M, Izumo S. 2003. Usefulness of proviral load measurement for monitoring of disease activity in individual patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. J Neurovirol 9:29-35. http://dx.doi.org/10.1080/13550280390173418.
9. Costa JM, Segurado AC. 2009. Molecular evidence of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) infections in HTLV seroindeterminate individuals from Sao Paulo, Brazil. J Clin Virol 44:185-189. http://dx.doi.org/10.1016/jjcv.2008.12.015.
10. Zanjani DS, Shahabi M, Talaei N, Afzalaghaee M, Tehranian F, Bazar-gani R. 2011. Molecular analysis of human T cell lymphotropic virus type 1 and 2 (HTLV-1/2) seroindeterminate blood donors from Northeast Iran: evidence of proviral tax, env, and gag sequences. AIDS Res Hum Retroviruses 27:131-135. http://dx.doi.org/10.1089/aid.2010.0017.
11. Watanabe M, Ohsugi T, Shoda M, Ishida T, Aizawa S, Maruyama-Nagai M, Utsunomiya A, Koga S, Yamada Y, Kamihira S, Okayama A, Kikuchi H, Uozumi K, Yamaguchi K, Higashihara M, Umezawa K, Watanabe T, Horie R. 2005. Dual targeting of transformed and untrans-formed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia. Blood 106:2462-2471. http://dx.doi.org/10.1182/blood-2004-09-3646.
12. Tanaka G, Okayama A, Watanabe T, Aizawa S, Stuver S, Mueller N, Hsieh CC, Tsubouchi H. 2005. The clonal expansion of human T lymphotropic virus type 1-infected T cells: a comparison between serocon-verters and long-term carriers. J Infect Dis 191:1140-1147. http://dx.doi.org/10.1086/428625.
13. Nagai M, Yamano Y, Brennan MB, Mora CA, Jacobson S. 2001. Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8 + T cells in cerebrospinal fluid from patients with HAM/TSP. Ann Neurol 50:807-812. http://dx.doi.org/10.1002/ana.10065.
14. Kamihira S, Dateki N, Sugahara K, Yamada Y, Tomonaga M, Maeda T, Tahara M. 2000. Real-time polymerase chain reaction for quantification of HTLV-1 proviral load: application for analyzing aberrant integration of the proviral DNA in adult T-cell leukemia. Int J Hematol 72:79-84.
15. Ueno S, Umeki K, Takajo I, Nagatomo Y, Kusumoto N, Umekita K, Morishita K, Okayama A. 2012. Proviral loads of human T-lymphotropic virus type 1 in asymptomatic carriers with different infection routes. Int J Cancer 130:2318-2326. http://dx.doi.org/10.1002/ijc.26289.
16. Kamihira S, Yamano Y, Iwanaga M, Sasaki D, Satake M, Okayama A, Umeki K, Kubota R, Izumo S, Yamaguchi K, Watanabe T. 2010. Intra-and inter-laboratory variability in human T-cell leukemia virus type-1 proviral load quantification using real-time polymerase chain reaction assays: a multi-center study. Cancer Sci 101:2361-2367. http://dx.doi.org/10.1111/j.1349-7006.2010.01720.x.
17. Sugamura K, Fujii M, Kannagi M, Sakitani M, Takeuchi M, Hinuma Y. 1984. Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus. Int J Cancer 34: 221-228. http://dx.doi.org/10.1002/ijc.2910340213.
18. Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. 1984. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci USA 81:2534-2537. http://dx.doi.org/10.1073/pnas.81.8.2534.
19. Yamaguchi K, Seiki M, Yoshida M, Nishimura H, Kawano F, Takatsuki K. 1984. The detection of human T cell leukemia virus proviral DNA and its application for classification and diagnosis of T cell malignancy. Blood 63:1235-1240.
20. Uren AG, Mikkers H, Kool J, van der Weyden L, Lund AH, Wilson CH, Rance R, Jonkers J, van Lohuizen M, Berns A, Adams DJ. 2009. A high-throughput Splinkerette-PCR method for the isolation and sequencing of retroviral insertion sites. Nat Protoc 4:789-798. http://dx.doi.org/10.1038/nprot.2009.64.
21. Sanger F, Nicklen S, Coulson AR. 1977. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463-5467. http://dx.doi.org/10.1073/pnas.74.12.5463.
22. World Health Organization. 2011. International collaborative study to establish the 3rd WHO international standard for HIV-1 NAT assays. WHO ECBS report 2011 WHO/BS/2011.2178. WHO, Geneva, Switzerland.
23. Fryer JF, Heath A, Wilkinson DE, Minor PD, The Collaborative Study Group. 2011. Collaborative study to evaluate the proposed 3rd WHO international standard for hepatitis B virus (HBV) for nucleic acid amplification technology (NAT)-based assays. WHO ECBS report 2011 WHO/BS/2011.2170. WHO, Geneva, Switzerland.
24. Fryer JF, Heath A, Wilkinson DE, Minor PD, The Collaborative Study Group. 2011. Collaborative study to evaluate the proposed 4th WHO international standard for hepatitis C virus (HCV) for nucleic acid amplification technology (NAT)-based assays. WHO ECBS report 2011 WHO/BS/2011.2173. WHO, Geneva, Switzerland.
25. White HE, Matejtschuk P, Rigsby P, Gabert J, Lin F, Lynn Wang Y, Branford S, Muller MC, Beaufils N, Beillard E, Colomer D, Dvorakova D, Ehrencrona H, Goh HG, El Housni H, Jones D, Kairisto V, Kamel-Reid S, Kim DW, Langabeer S, Ma ES, Press RD, Romeo G, Wang L, Zoi K, Hughes T, Saglio G, Hochhaus A, Goldman JM, Metcalfe P, Cross NC. 2010. Establishment of the first World Health Organization international genetic reference panel for quantitation of BCR-ABL mRNA. Blood 116:e111-e117. http://dx.doi.org/10.1182/blood-2010-06-291641.
26. Koiwa T, Hamano-Usami A, Ishida T, Okayama A, Yamaguchi K, Kamihira S, Watanabe T. 2002. 5=-Long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo. J Virol 76:9389-9397. http://dx.doi.org/10.1128/JVI.76.18.9389-9397.2002.
27. Ishida T, Hamano A, Koiwa T, Watanabe T. 2006. 5= Long terminal repeat (LTR)-selective methylation of latently infected HIV-1 provirus that is demethylated by reactivation signals. Retrovirology 3:69. http://dx.doi.org/10.1186/1742-4690-3-69.
28. Firouzi S, Lopez Y, Suzuki Y, Nakai K, Sugano S, Yamochi T, Watanabe T. 2014. Development and validation of a new high-throughput method to investigate the clonality of HTLV-1-infected cells based on provirus integration sites. Genome Med 6:46. http://dx.doi.org/10.1186/gm568.